251 related articles for article (PubMed ID: 30824356)
1. Pneumocystis pneumonia in HIV-1-infected patients.
Shibata S; Kikuchi T
Respir Investig; 2019 May; 57(3):213-219. PubMed ID: 30824356
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis carinii infections in HIV-infected children.
Sanders-Laufer D; DeBruin W; Edelson PJ
Pediatr Clin North Am; 1991 Feb; 38(1):69-88. PubMed ID: 1987519
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection.
Mueller BU; Butler KM; Husson RN; Pizzo PA
J Pediatr; 1991 Dec; 119(6):992-4. PubMed ID: 1960625
[No Abstract] [Full Text] [Related]
4. Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-gamma and reduced doses of trimethoprim/sulfamethoxazole.
Shear HL; Valladares G; Narachi MA
J Acquir Immune Defic Syndr (1988); 1990; 3(10):943-8. PubMed ID: 2118951
[TBL] [Abstract][Full Text] [Related]
5. [Pneumonia due to Pneumocystis carinii in HIV-infected children].
Morales-Aguirre JJ; Villalobos-Acosta CP; Linares-Salas VH; Solís-Ortega AM; Gómez-Barreto D; Cashat-Cruz M
Gac Med Mex; 2004; 140(1):59-69. PubMed ID: 15022888
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial therapy for patients with HIV infection].
Koibuchi T; Iwamoto A
Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2214-9. PubMed ID: 17168395
[No Abstract] [Full Text] [Related]
7. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus.
Zar HJ; Dechaboon A; Hanslo D; Apolles P; Magnus KG; Hussey G
Pediatr Infect Dis J; 2000 Jul; 19(7):603-7. PubMed ID: 10917216
[TBL] [Abstract][Full Text] [Related]
8. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
9. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
[TBL] [Abstract][Full Text] [Related]
10. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.
Ruskin J; LaRiviere M
Lancet; 1991 Feb; 337(8739):468-71. PubMed ID: 1671479
[TBL] [Abstract][Full Text] [Related]
11. When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
Dameron M; Horowitz M; Gupta N; Abi Hatem N
JAAPA; 2021 Feb; 34(2):24-26. PubMed ID: 33470717
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
13. The outcome of Pneumocystis carinii pneumonia in Danish patients with AIDS.
Pedersen C; Lundgren JD; Nielsen T; Andersen WH
Scand J Infect Dis; 1989; 21(4):375-80. PubMed ID: 2587939
[TBL] [Abstract][Full Text] [Related]
14. [Pneumocystis jirovecii pneumonia-an opportunistic infection undergoing change].
Hitzenbichler F; Mohr A; Salzberger B
Internist (Berl); 2019 Jul; 60(7):669-677. PubMed ID: 31089770
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV.
Connor E; Bagarazzi M; McSherry G; Holland B; Boland M; Denny T; Oleske J
JAMA; 1991 Apr; 265(13):1693-7. PubMed ID: 1672168
[TBL] [Abstract][Full Text] [Related]
18. Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.
Kovacs JA; Masur H
JAMA; 2009 Jun; 301(24):2578-85. PubMed ID: 19549975
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus (HIV)-associated pneumocystosis.
Armstrong D; Bernard EM
Curr Clin Top Infect Dis; 1991; 11():19-34. PubMed ID: 1867767
[No Abstract] [Full Text] [Related]
20. Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia.
Davey RT; Masur H
Antimicrob Agents Chemother; 1990 Apr; 34(4):499-504. PubMed ID: 2140495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
